Silverfin false true 31/01/2025 01/02/2024 31/01/2025 Lisa Delamaine 30/01/2023 07 August 2025 no description of principal activity 14625375 2025-01-31 14625375 bus:Director1 2025-01-31 14625375 2024-01-31 14625375 core:ShareCapital 2025-01-31 14625375 core:ShareCapital 2024-01-31 14625375 bus:OrdinaryShareClass1 2025-01-31 14625375 2024-02-01 2025-01-31 14625375 bus:FilletedAccounts 2024-02-01 2025-01-31 14625375 bus:SmallEntities 2024-02-01 2025-01-31 14625375 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 14625375 bus:EntityHasNeverTraded 2024-02-01 2025-01-31 14625375 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 14625375 bus:Director1 2024-02-01 2025-01-31 14625375 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 14625375 bus:OrdinaryShareClass1 2023-02-01 2024-01-31 iso4217:GBP xbrli:shares

Company No: 14625375 (England and Wales)

DR LISA DELAMAINE LTD

Unaudited Financial Statements
For the financial year ended 31 January 2025
Pages for filing with the registrar

DR LISA DELAMAINE LTD

Unaudited Financial Statements

For the financial year ended 31 January 2025

Contents

DR LISA DELAMAINE LTD

COMPANY INFORMATION

For the financial year ended 31 January 2025
DR LISA DELAMAINE LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 January 2025
Director Lisa Delamaine
Registered office 7a Sweechgate
Broad Oak
Canterbury
England
CT2 0QY
United Kingdom
Company number 14625375 (England and Wales)
Accountant Kreston Reeves LLP
2nd Floor, Maritime Place
Quayside
Chatham Maritime
Chatham
Kent
ME4 4QZ
DR LISA DELAMAINE LTD

BALANCE SHEET

As at 31 January 2025
DR LISA DELAMAINE LTD

BALANCE SHEET (continued)

As at 31 January 2025
Note 2025 2024
£ £
Current assets
Cash at bank and in hand 1 1
1 1
Net current assets 1 1
Total assets less current liabilities 1 1
Net assets 1 1
Capital and reserves
Called-up share capital 2 1 1
Total shareholder's funds 1 1

Dr Lisa Delamaine Ltd (registered number: 14625375) did not trade during the current or preceding financial year and has made neither profit nor loss, nor any other comprehensive income. There have been no movements in shareholders’ funds during the current or preceding financial year and therefore no Statement of Changes of Equity has been included. For the financial year ending 31 January 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The financial statements of Dr Lisa Delamaine Ltd (registered number: 14625375) were approved and authorised for issue by the Director on 07 August 2025. They were signed on its behalf by:

Lisa Delamaine
Director
DR LISA DELAMAINE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2025
DR LISA DELAMAINE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dr Lisa Delamaine Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 7a Sweechgate, Broad Oak, Canterbury, England, CT2 0QY, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

2. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1 1